Alto Neuroscience
ANRO
23.52
-0.17
-0.72%
Alto Neuroscience
US · ANRO
#3301 by market cap
Listed 2024
23.52
-0.17
-0.72%
Live - 5344 symbols - heartbeat 258s ago
· 2026-10-08 09:17
Pre-market
23.24
-1.19%
After-hours
23.97
+1.92%
- Market cap
- 922.97M
- P/E (TTM)i
- -10.14
- P/Bi
- 4.21
- EPSi
- -2.19
- Div yieldi
- 0.00%
- 52W posi
- 57%
Reader sentiment
Are you bullish or bearish on ANRO?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 5 years
Margins
Key ratios & quality
- Enterprise valuei
- 766.63M
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 210.00K | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- |
| Selling & admin expenses | 3.90M | 5.50M | 7.52M | 21.61M | 20.75M |
| Research & development | 8.37M | 23.69M | 30.29M | 47.00M | 45.62M |
| Operating profit | -9.08M | -27.46M | -37.81M | -68.61M | -66.36M |
| Pretax profit | -9.19M | -27.71M | -36.31M | -61.43M | -63.24M |
| Tax | -- | -- | -- | -- | -- |
| Net profit | -9.19M | -27.71M | -36.31M | -61.43M | -63.24M |
| Basic EPS | -1 | -2 | -1 | -3 | -2 |
| Diluted EPS | -0.94 | -2.13 | -1.42 | -2.50 | -2.19 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | -- | 0 | 0 |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 5.70M | 5.56M | 4.43M | 5.06M | 6.84M | 7.02M |
| Research & development | 9.97M | 13.12M | 10.53M | 12.00M | 20.29M | 22.11M |
| Operating profit | -15.68M | -18.68M | -14.95M | -17.06M | -27.14M | -29.13M |
| Pretax profit | -15.17M | -17.71M | -14.18M | -16.18M | -26.24M | -27.64M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -15.17M | -17.71M | -14.18M | -16.18M | -26.24M | -27.64M |
| Basic EPS | -1 | -1 | -1 | 0 | -1 | -1 |
| Diluted EPS | -0.56 | -0.65 | -0.52 | -0.45 | -0.80 | -0.65 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 27.68M | 49.22M | 85.39M | 169.34M | 177.72M |
| Cash & ST investments | 25.71M | 48.34M | 82.55M | 168.23M | 176.48M |
| Inventory | -- | -- | -- | -- | -- |
| Total assets | 28.79M | 50.85M | 86.63M | 177.54M | 184.69M |
| Total current liabilities | 1.81M | 5.56M | 5.61M | 10.01M | 11.33M |
| Short-term debt | -- | 283.00K | 125.00K | 870.00K | 1.74M |
| Long-term debt | -- | 9.47M | 9.86M | 11.56M | 18.40M |
| Total liabilities | 41,272,000.00 | 89,260,000.00 | 158,300,000.00 | 26,082,000.00 | 33,547,000.00 |
| Total equity | -12.48M | -38.41M | -71.67M | 151.46M | 151.14M |
| Retained earnings | -12.95M | -40.66M | -76.97M | -138.40M | -201.63M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 163.52M | 149.85M | 139.45M | 177.72M | 269.13M | 247.32M |
| Cash & ST investments | 160.75M | 147.59M | 137.82M | 176.48M | 263.76M | 243.73M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 171.92M | 157.88M | 147.01M | 184.69M | 276.26M | 254.07M |
| Total current liabilities | 7.26M | 8.13M | 9.05M | 11.33M | 13.12M | 16.65M |
| Short-term debt | 876.00K | 973.00K | 1.12M | 1.74M | 3.44M | 5.13M |
| Long-term debt | 21.15M | 22.12M | 22.44M | 18.40M | 16.22M | 14.88M |
| Total liabilities | 32,819,000.00 | 34,465,000.00 | 35,449,000.00 | 33,547,000.00 | 32,890,000.00 | 34,817,000.00 |
| Total equity | 139.10M | 123.41M | 111.56M | 151.14M | 243.37M | 219.25M |
| Retained earnings | -153.57M | -171.27M | -185.45M | -201.63M | -227.87M | -255.51M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -9.26M | -20.39M | -33.45M | -47.42M | -51.77M |
| Depreciation & amortization | 145.00K | 342.00K | 373.00K | 502.00K | 661.00K |
| Free cash flow | -9.94M | -21.13M | -33.92M | -49.50M | -51.79M |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 7.00K | 43.00K | 0 | 137.58M | 49.83M |
| Ending cash balance | 25.71M | 48.34M | 82.55M | 168.73M | 176.98M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -16.56M | -13.78M | -9.92M | -11.52M | -27.09M | -19.76M |
| Depreciation & amortization | 171.00K | 169.00K | 164.00K | 157.00K | 184.00K | 184.00K |
| Free cash flow | -16.58M | -13.78M | -9.92M | -11.52M | -27.65M | -19.76M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 0 | 49.83M | 115.13M | -348.00K |
| Ending cash balance | 161.25M | 148.09M | 138.32M | 176.98M | 264.26M | 244.23M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -153.99 | -41.80 |
| ROA %i | -31.91 | -69.58 | -52.81 | -46.51 | -34.92 |
| ROIC %i | -- | -- | -- | -129.14 | -39.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -4,324.76 | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- |
| Current ratioi | 15.30 | 8.85 | 15.22 | 16.92 | 15.69 |
| Quick ratioi | 15.16 | 8.75 | 14.71 | 16.81 | 15.58 |
| Debt / assetsi | 0.00 | 19.17 | 11.53 | 9.54 | 12.97 |
| LT debt / equityi | -- | -- | -- | 10.61 | 14.70 |
| Interest coveragei | -- | -- | -25.50 | -43.68 | -24.61 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -38.04 | -42.78 | -45.01 | -41.80 | -38.86 | -49.17 |
| ROA %i | -33.09 | -36.52 | -36.77 | -34.92 | -33.16 | -40.90 |
| ROIC %i | -38.34 | -41.74 | -41.88 | -39.23 | -36.21 | -45.13 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 22.53 | 18.43 | 15.42 | 15.69 | 20.52 | 14.85 |
| Quick ratioi | 22.15 | 18.16 | 15.24 | 15.58 | 20.11 | 14.64 |
| Debt / assetsi | 15.38 | 17.30 | 18.72 | 12.97 | 8.40 | 9.17 |
| LT debt / equityi | 18.38 | 21.34 | 23.67 | 14.70 | 8.13 | 8.29 |
| Interest coveragei | -37.83 | -32.68 | -26.96 | -24.61 | -29.76 | -36.26 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 09:17:13 · For reference only, not investment advice and not tailored to your situation.